Enzyme manufacturer announces new appointments

Specialty enzyme manufacturer Biocatalysts Ltd. has named Craig Galeozzie as operations manager, Craig Phillips as financial controller and Dr. Andrew Ellis as technical director. The appointments will help the company implement a project to build a new enzyme production plant at the headquarters in Cardiff, South Wales, which will transform the production capabilities that Biocatalysts will be able to offer customers.

Specialty enzyme manufacturer Biocatalysts Ltd. has named Craig Galeozzie as operations manager, Craig Phillips as financial controller and Dr. Andrew Ellis as technical director. The appointments will help the company implement a project to build a new enzyme production plant at the headquarters in Cardiff, South Wales, which will transform the production capabilities that Biocatalysts will be able to offer customers.

Galeozzie has over 20 years management experience within automotive, electronics and biotechnology industries. His most recent employment was at Harman International and was a key strategist in the organization's transfer of manufacturing to China. He has also managed manufacturing activity in Japan, Hungary, Germany, France and the U.S. This experience, along with a master's degree in business management, makes him an asset to Biocatalysts.

Galeozzie will manage and develop the operations department to ensure customer needs are met in an efficient and cost effective manner while implementing a strategy of constant improvement and providing commercial business acumen to the organization. He commented: "I spent the majority of 2012 setting up a new manufacturing facility in China but decided to make the move back to the UK to take up this position at Biocatalysts. My experience has been generated from large companies and I am now looking forward to making a difference within a small company, especially with the challenges and growth possibilities that will be presented with the implementation of a new £$2 million enzyme production plant."

Phillips first joined the company in 2006 as an accounts assistant and has since progressed through his certified accountant exams to further his career at Biocatalysts. In his role, Phillips will be responsible for the day-to-day finances, which will become an imperative duty as the enzyme production plant project progresses. He will help guide the company through any business decisions and facilitate key strategic decisions by providing regular, accurate and reliable management reporting to the senior management team.

Ellis, who originally joined the company as a new product development scientist, will focus on developing the company's range of enzyme manufacturing capabilities, which will drive down the cost and time it takes to produce unique enzymes for customers. Previously only an option for larger food companies, novel enzymes will become common aid in producing a wide range of end products from processed cheese to pharmaceuticals.

Page 1 of 51
Next Page